Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$220K Hold
773
0.05% 240
2023
Q4
$223K Sell
773
-2,333
-75% -$636K 0.06% 226
2023
Q3
$835K Sell
3,106
-12
-0.4% -$3K 0.2% 113
2023
Q2
$692K Buy
3,118
+1,232
+65% +$286K 0.16% 148
2023
Q1
$456K Buy
1,886
+728
+63% +$179K 0.11% 194
2022
Q4
$304K Sell
1,158
-112
-9% -$30K 0.07% 251
2022
Q3
$286K Sell
1,270
-295
-19% -$71.5K 0.07% 254
2022
Q2
$381K Buy
1,565
+71
+5% +$17.4K 0.07% 258
2022
Q1
$361K Buy
+1,494
New +$343K 0.06% 291
2021
Q3
$335K Sell
1,576
-109
-6% -$25.1K 0.06% 289
2021
Q2
$411K Sell
1,685
-30
-2% -$7.38K 0.08% 254
2021
Q1
$427K Sell
1,715
-50
-3% -$11.9K 0.09% 219
2020
Q4
$405K Buy
1,765
+11
+0.6% +$2.54K 0.09% 212
2020
Q3
$446K Buy
1,754
+257
+17% +$63.7K 0.11% 188
2020
Q2
$353K Buy
1,497
+19
+1% +$4.33K 0.13% 171
2020
Q1
$300K Buy
1,478
+112
+8% +$24.5K 0.13% 168
2019
Q4
$329K Buy
+1,366
New +$301K 0.13% 178

Other funds holding AMGN

Eudaimonia Partners's AMGN Position: Q1 2024 in Review

Eudaimonia Partners held its Amgen (AMGN) position steady in Q1 2024 at 773 shares worth $220K. The position accounts for 0.05% of the portfolio, ranked #240.

Eudaimonia Partners first reported a position in AMGN in Q4 2019 and has held it in 17 quarters since. The position peaked at $835K in Q3 2023. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

  • Eudaimonia Partners held 773 shares of Amgen worth $220K as of Q1 2024.
  • Eudaimonia Partners left its Amgen share count unchanged in Q1 2024.
  • Amgen made up 0.05% of Eudaimonia Partners's portfolio in Q1 2024, its #240 holding.
  • Eudaimonia Partners first reported a position in Amgen in Q4 2019 and has held it in 17 quarters since.
  • Eudaimonia Partners's Amgen position peaked at $835K in Q3 2023.
  • 2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on Eudaimonia Partners's 13F filing for Q1 2024, filed 25 Apr 2024.